ReviewEuropean journal of clinical pharmacology2022

Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.

Vitória Segabinazzi Foletto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.